Add-on to Thiazolidinedione (TZD) Failures

NCT00683878 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

972

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Dapagliflozin
DRUG: Dapagliflozin
DRUG: Placebo matching Dapagliflozin
DRUG: Thiazolidinedione (Pioglitazone)

Sponsor

AstraZeneca

Collaborators

[object Object]